Select for export Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1300005 PubMed 12496954 Copy citation Copy BibTeX Unknown journal 2002-12-31 Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T Europe PMC Published psilocybin PharmacologyReceptor PharmacologyHealthy Volunteers Other More
Select for export Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-002-1237-5 PubMed 12474114 Copy citation Copy BibTeX Unknown journal 2002-10-11 Riba J, Rodríguez-Fornells A, Barbanoj MJ. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0006-3223(01)01242-2 PubMed 11904134 Copy citation Copy BibTeX Unknown journal 2002-02-28 Umbricht D, Koller R, Vollenweider FX, Schmid L. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More
Select for export A systems model of altered consciousness: integrating natural and drug-induced psychoses. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0361-9230(01)00646-3 PubMed 11750795 Copy citation Copy BibTeX Unknown journal 2001-10-31 Vollenweider FX, Geyer MA. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Other More
Select for export Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/jm000339w PubMed 11101361 Copy citation Copy BibTeX Unknown journal 2000-10-31 Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL Europe PMC Published psilocin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/jm990325u PubMed 10514296 Copy citation Copy BibTeX Unknown journal 1999-09-30 Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE. Europe PMC Published psilocin PharmacologyReceptor PharmacologyIn Vitro Study In Vitro Study More
Select for export 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0893-133x(98)00108-0 PubMed 10192823 Copy citation Copy BibTeX Unknown journal 1999-04-30 Vollenweider FX, Vontobel P, Hell D, Leenders KL. Europe PMC Published psilocybin Receptor PharmacologyHealthy VolunteersDrug Interactions Other More
Select for export Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/00001756-199812010-00024 PubMed 9875725 Copy citation Copy BibTeX Unknown journal 1998-11-30 Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0893-133x(96)00246-1 PubMed 9109107 Copy citation Copy BibTeX Unknown journal 1997-04-30 Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J. Europe PMC Published psilocybin PharmacologyReceptor PharmacologyHealthy Volunteers Other More
Select for export Stimulation of rat prolactin secretion by indolealkylamine hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/bf00432847 PubMed 148665 Copy citation Copy BibTeX Unknown journal 1978-03-31 Meltzer HY, Fessler RG, Simonovic M, Fang VS. Europe PMC Published psilocybin Receptor PharmacologyAnimal Study Animal Study More
Select for export Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/0014-2999(77)90097-8 PubMed 560306 Copy citation Copy BibTeX Unknown journal 1977-06-30 Trulson ME, Stark AD, Jacobs BL. Europe PMC Published psilocin Mechanism of ActionReceptor Pharmacology Other More
Select for export Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/0006-8993(75)90876-8 PubMed 238721 Copy citation Copy BibTeX Unknown journal 1975-07-31 Hungen KV, Roberts S, Hill DF. Europe PMC Published psilocin Receptor PharmacologyAnimal StudyDrug Interactions Animal Study More
